Details of the Drug

General Information of Drug (ID: DML4SIE)

Drug Name
Atu-027
Synonyms PI3K expression inhibitors (AtuPLEX, cancer), Atugen; Phosphoinositide 3 kinase expression inhibitors (AtuPLEX, cancer), Atugen
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
DrugBank ID
DB12171
TTD ID
D09TGT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein kinase N3 (PKN3) TTW3P4R PKN3_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00938574) Study With Atu027 in Patients With Advanced Solid Cancer. U.S. National Institutes of Health.
2 Company report (Silence Therapeutics)